EU Biologics Co., Ltd.

횡성태기산산양삼.png

CEO

Baek young ok, Choi seon guen

207, Dosan-daero, Gangnam-gu, Seoul, Republic of Korea

Company Overview

EU Biologics Co., Ltd. is a specialized bio company that develops new vaccine products with the aim of providing safe and effective vaccines that contribute to the promotion of global public health, while providing CRMO services regarding various bio-medicines. Its human resources are steeped in bio-medicine research and production and boast extensive experience in the relevant field.

History

(주)아랜디.png

Outcome

- Certification of ISO 9001, 14001, 13485
- Certification as excellent brain capacity specialty company
- Certification as venture business
- Accreditation as corporate affiliate R&D institute
- Permit to manufacture medicines
- Permit to manufacture medical devices
- 2017 Gangwon Businessmen Award (R&D Award)
- 2018 Korea Technology Awards
- 2018 $10 Million Export Tower
- Presidential Prize for 2019 Contribution to Regional Industry Promotion
- 2019 $20 Million Export Tower
- 2019 Gangwon Export Awards
- Patent application for pneumococcal polysaccharide-protein joint vaccine and its use through new linkers
- Patent application for production method of Streptococcus Pneumonia capsular polysaccharide
- Patent application for production method of rCRM197 using recombinant E. coli
- Patent application for immunogenic composition containing the polyvalent pneumococcal polysaccharide-protein zygote and its pharmacological composition
- Patent application for the immunogenic composition containing the polyvalent pneumococcal polysaccharide-protein zygote and for a vaccine preventing diseases caused by pneumococcal bacteria
- Patent application for corynebacterium strains manifesting CRM197 at a high concentration
- Patent application for new antibodies and their use
- Patent application for CRM protein manifesting method
- Patent application for method of producing monophosphoryl lipid A